Skip to content

Clinical trials

Phase 2 Melanoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 2 Country / region: Austria Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20064
20081
20101
20111
20131
20141
20152
20162
20171
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
European Organisation for Research and Treatment of Cancer - EORTC3
Philogen S.p.A.2
Amgen1
AstraZeneca1
Eli Lilly and Company1
Fondazione Melanoma Onlus1
Incyte Corporation1
Medical University of Vienna1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma20
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Renal Cell2
Neoplasm Metastasis2
Brain Neoplasms1
Breast Neoplasms1
Head and Neck Neoplasms1
Lung Neoplasms1
Pancreatic Neoplasms1
Skin Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.